[2]
[14]
[29]
[35]
[24]
[28]
[25]
Study plan: prospective/retospective
+/-
+
+/-
+/-
-/+
-/+
-/+
Double masked study
+
UK
+
+
-
-
-
Randomiztion
+
UK
+
+
-
-
-
Quantity of myopia
1-6 D
≥ 3D
1-6 D
-0.5-5.5 D
<+1 (premyopia)
UK
Group size (individuals)
246
46
186
96
114
50
117
Follow up (years)
2
1
2
1
1
1
4.5
Concentration
1%
1%
0.5% 0.25% 0.1%
1%
0.5%
0.025%
Dosage
1 daily
1 daily
1 daily
1 daily
1 daily
1 daily
1 daily
Results: D/year (atropine group vs control group)
-0.28± 0.92 vs -1.2± 0.69
0.06vs 1.19
-0.04±0.63 -0.45±0.55 -0.47±0.91
-0.219 vs -0.914
-0.25±0.26 vs -0.75±0.35
-0.14±0.24 vs -0.58±0.34
-0.23 vs -0.86
UK: Unknow; D: Diopter
Table 2:
Study outcomes and results of the main clinical trials.
